BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17684496)

  • 21. Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio.
    Buerger K; Ernst A; Ewers M; Uspenskaya O; Omerovic M; Morgenthaler NG; Knauer K; Bergmann A; Hampel H
    Biol Psychiatry; 2009 Jun; 65(11):979-84. PubMed ID: 19344890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease.
    Tei E; Yamamoto H; Watanabe T; Miyazaki A; Nakadate T; Kato N; Mimura M
    Growth Horm IGF Res; 2008 Feb; 18(1):47-54. PubMed ID: 17714966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Commonalities in the genetics of Alzheimer's disease and Parkinson's disease.
    Grünblatt E
    Expert Rev Neurother; 2008 Dec; 8(12):1865-77. PubMed ID: 19086884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional significance of minor structural and expression changes in stress chaperone mortalin.
    Deocaris CC; Widodo N; Ishii T; Kaul SC; Wadhwa R
    Ann N Y Acad Sci; 2007 Nov; 1119():165-75. PubMed ID: 18056964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.
    Jung SM; Lee K; Lee JW; Namkoong H; Kim HK; Kim S; Na HR; Ha SA; Kim JR; Ko J; Kim JW
    Neurosci Lett; 2008 May; 436(2):153-7. PubMed ID: 18378077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infrared spectroscopy: a reagent-free method to distinguish Alzheimer's disease patients from normal-aging subjects.
    Peuchant E; Richard-Harston S; Bourdel-Marchasson I; Dartigues JF; Letenneur L; Barberger-Gateau P; Arnaud-Dabernat S; Daniel JY
    Transl Res; 2008 Sep; 152(3):103-12. PubMed ID: 18774539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia.
    Boban M; Grbić K; Mladinov M; Hof PR; Süssmair C; Ackl N; Stanić G; Bader B; Danek A; Simić G
    Coll Antropol; 2008 Jan; 32 Suppl 1():31-6. PubMed ID: 18405055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics and pharmagenomics, trends in normal and pathological aging studies: focus on p53.
    Lanni C; Racchi M; Uberti D; Mazzini G; Stanga S; Sinforiani E; Memo M; Govoni S
    Curr Pharm Des; 2008; 14(26):2665-71. PubMed ID: 18991686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unfolded p53 as a Marker of Oxidative Stress in Mild Cognitive Impairment, Alzheimer's and Parkinson's Disease.
    García S; Amor-Gutiérrez O; Palomares-Albarrán M; Toyos-Rodríguez C; Cuetos F; Martínez C; Costa-García A; Fernández-Sánchez MT; de la Escosura-Muñiz A; Novelli A
    Curr Alzheimer Res; 2021; 18(9):695-700. PubMed ID: 34789127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune blood biomarkers of Alzheimer disease patients.
    Avagyan H; Goldenson B; Tse E; Masoumi A; Porter V; Wiedau-Pazos M; Sayre J; Ong R; Mahanian M; Koo P; Bae S; Micic M; Liu PT; Rosenthal MJ; Fiala M
    J Neuroimmunol; 2009 May; 210(1-2):67-72. PubMed ID: 19329192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
    Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of the Ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function.
    Arias-Vásquez A; de Lau L; Pardo L; Liu F; Feng BJ; Bertoli-Avella A; Isaacs A; Aulchenko Y; Hofman A; Oostra B; Breteler M; van Duijn C
    Neurosci Lett; 2007 Aug; 424(1):1-5. PubMed ID: 17709205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression.
    Motta M; Imbesi R; Di Rosa M; Stivala F; Malaguarnera L
    Immunol Lett; 2007 Nov; 114(1):46-51. PubMed ID: 17949824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease.
    Muck-Seler D; Presecki P; Mimica N; Mustapic M; Pivac N; Babic A; Nedic G; Folnegovic-Smalc V
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1226-31. PubMed ID: 19602426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sugar chains of cerebrospinal fluid transferrin as a new biological marker of Alzheimer's disease.
    Taniguchi M; Okayama Y; Hashimoto Y; Kitaura M; Jimbo D; Wakutani Y; Wada-Isoe K; Nakashima K; Akatsu H; Furukawa K; Arai H; Urakami K
    Dement Geriatr Cogn Disord; 2008; 26(2):117-22. PubMed ID: 18654083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is late-onset schizophrenia related to neurodegenerative processes? A review of literature].
    Lagodka A; Robert P
    Encephale; 2009 Sep; 35(4):386-93. PubMed ID: 19748376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased expression of CD33 in peripheral mononuclear cells of Alzheimer's disease patients.
    Hu N; Tan MS; Sun L; Jiang T; Wang YL; Tan L; Zhang W; Yu JT; Tan L
    Neurosci Lett; 2014 Mar; 563():51-4. PubMed ID: 24412678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.